OverviewSuggest Edit

metaLinear is a biotech company producing drug targets designed to treat bacterial infections. The company's targets use a proteome engineering technology to uncover, characterize, and validate new targets for antibiotics, that helps drug developers in their drug discovery workflows.

Latest Updates

Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

metaLinear Financials and Metrics

Summary Metrics

Founding Date


metaLinear total Funding

$338.4 k

metaLinear latest funding size

$338.38 k

Time since last funding

5 years ago

metaLinear investors

metaLinear's latest funding round in November 2017 was reported to be $338.4 k. In total, metaLinear has raised $338.4 k
Show all financial metrics

metaLinear Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

metaLinear Online and Social Media Presence

Embed Graph

metaLinear Frequently Asked Questions

  • When was metaLinear founded?

    metaLinear was founded in 2016.

  • Who are metaLinear competitors?

    Competitors of metaLinear include Covis Pharmaceuticals, Medicago and Ascendis Pharma.